JP2006508665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006508665A5 JP2006508665A5 JP2004557611A JP2004557611A JP2006508665A5 JP 2006508665 A5 JP2006508665 A5 JP 2006508665A5 JP 2004557611 A JP2004557611 A JP 2004557611A JP 2004557611 A JP2004557611 A JP 2004557611A JP 2006508665 A5 JP2006508665 A5 JP 2006508665A5
- Authority
- JP
- Japan
- Prior art keywords
- butyrylcholinesterase
- butyrylcholinesterase variant
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31066602A | 2002-12-04 | 2002-12-04 | |
| PCT/US2003/038684 WO2004050041A2 (en) | 2002-12-04 | 2003-12-04 | Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006508665A JP2006508665A (ja) | 2006-03-16 |
| JP2006508665A5 true JP2006508665A5 (cg-RX-API-DMAC7.html) | 2007-02-01 |
Family
ID=32468084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004557611A Pending JP2006508665A (ja) | 2002-12-04 | 2003-12-04 | 化学療法剤の活性を変化させるブチリルコリンエステラーゼ変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080213281A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1581253A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006508665A (cg-RX-API-DMAC7.html) |
| CN (1) | CN100341568C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003298920A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0316865A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2507626A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05005996A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004050041A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989261B2 (en) * | 2001-12-20 | 2006-01-24 | Eli Lilly And Company | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| AR044388A1 (es) * | 2003-05-20 | 2005-09-07 | Applied Molecular Evolution | Moleculas de union a cd20 |
| EP2049661A4 (en) * | 2006-08-04 | 2012-07-04 | Pharmathene Inc | RECOMBINANT BUTYRYLCHOLINESTERASE WITH LONG HALF-LIFE |
| US20100009390A1 (en) * | 2008-05-09 | 2010-01-14 | The Regents Of The University Of California | Mutant antibodies with high affinity for egfr |
| US20100008978A1 (en) * | 2008-05-09 | 2010-01-14 | The Regents Of The University Of California | Nanoparticles effective for internalization into cells |
| WO2009139905A2 (en) * | 2008-05-16 | 2009-11-19 | Nektar Therapeutics | Conjugates of a cholinesterase moiety and a polymer |
| CA2784861A1 (en) | 2009-12-21 | 2011-07-14 | Pharmathene, Inc. | Recombinant butyrylcholinesterases and truncates thereof |
| CN103898101B (zh) * | 2012-12-27 | 2017-08-08 | 上海桀蒙生物技术有限公司 | 利用转基因动物乳腺生物平台大规模生产重组人丁酰胆碱酯酶的方法 |
| CN104630177A (zh) * | 2013-11-08 | 2015-05-20 | 中国农业大学 | 一种利用人丁酰胆碱酯酶迷你基因在乳腺中表达重组人丁酰胆碱脂酶的方法 |
| EP3719123A1 (en) | 2014-04-29 | 2020-10-07 | Mayo Foundation for Medical Education and Research | Uses of butyrylcholinesterase variants having an enhanced ability to hydrolyze acyl-ghrelin |
| WO2018053216A1 (en) * | 2016-09-15 | 2018-03-22 | Mayo Foundation For Medical Education And Research | Methods and materials for using butyrylcholinesterases to treat cancer |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1008049A1 (en) * | 1987-09-11 | 1999-04-30 | Whitehead Institute For Biomedical Research | Transduced fibroblasts and use therefor |
| US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5264563A (en) * | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
| US5643578A (en) * | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| US5620896A (en) * | 1992-03-23 | 1997-04-15 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
| US5506125A (en) * | 1993-12-22 | 1996-04-09 | Agracetus, Inc. | Gene delivery instrument with replaceable cartridges |
| US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5656465A (en) * | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
| US6001625A (en) * | 1995-05-19 | 1999-12-14 | The United States Of America As Represented By The Secretary Of The Army | Site-directed mutagenesis of esterases |
| ATE317452T1 (de) * | 1998-06-16 | 2006-02-15 | Nova Molecular Inc | Verfahren zur behandlung von neurologischen erkrankungen mit hilfe der bestimmung des bche genotyps |
| CN1331339A (zh) * | 2000-06-26 | 2002-01-16 | 上海博德基因开发有限公司 | 一种新的多肽——人dna拓扑异构酶i11.44和编码这种多肽的多核苷酸 |
| AU2002248256B2 (en) * | 2000-12-26 | 2006-09-28 | Applied Molecular Evolution, Inc. | Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| US20030153062A1 (en) * | 2001-12-20 | 2003-08-14 | Watkins Jeffry D. | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| US7070973B2 (en) * | 2000-12-26 | 2006-07-04 | Board Of Regents Of The University Of Nebraska | Butyrylcholinesterase variants and methods of use |
| US7049121B2 (en) * | 2001-12-20 | 2006-05-23 | Applied Molecular Evolution | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| US6989261B2 (en) * | 2001-12-20 | 2006-01-24 | Eli Lilly And Company | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
-
2003
- 2003-12-04 AU AU2003298920A patent/AU2003298920A1/en not_active Abandoned
- 2003-12-04 BR BR0316865-4A patent/BR0316865A/pt not_active IP Right Cessation
- 2003-12-04 CN CNB2003801050807A patent/CN100341568C/zh not_active Expired - Fee Related
- 2003-12-04 WO PCT/US2003/038684 patent/WO2004050041A2/en not_active Ceased
- 2003-12-04 CA CA002507626A patent/CA2507626A1/en not_active Abandoned
- 2003-12-04 MX MXPA05005996A patent/MXPA05005996A/es not_active Application Discontinuation
- 2003-12-04 JP JP2004557611A patent/JP2006508665A/ja active Pending
- 2003-12-04 US US10/535,441 patent/US20080213281A1/en not_active Abandoned
- 2003-12-04 EP EP03796682A patent/EP1581253A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kroutil et al. | Exonucleolytic proofreading during replication of repetitive DNA | |
| Lee et al. | Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination | |
| KR102761827B1 (ko) | 타입 vi-b crispr 효소 및 시스템 | |
| Cui et al. | Structure–function analysis of the inverted terminal repeats of the Sleeping Beauty transposon | |
| CN106103699B (zh) | 体细胞单倍体人类细胞系 | |
| Zaret et al. | Site-directed mutagenesis reveals a liver transcription factor essential for the albumin transcriptional enhancer. | |
| Edgell et al. | Mobile DNA elements in T4 and related phages | |
| JPH07502898A (ja) | 酵素rna分子 | |
| CA2306188A1 (en) | A novel method for the integration of foreign dna into eukaryotic genomes | |
| CN103911376A (zh) | CRISPR-Cas9靶向敲除乙肝病毒cccDNA及其特异性sgRNA | |
| CA2963820A1 (en) | Methods for improving crispr/cas-mediated genome-editing | |
| JP2009542228A5 (cg-RX-API-DMAC7.html) | ||
| CN107513538A (zh) | 基因敲除方法 | |
| AU2002304258A1 (en) | Method for the stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof | |
| Oh et al. | A multiplex guide RNA expression system and its efficacy for plant genome engineering | |
| WO2023092132A1 (en) | Effector proteins and uses thereof | |
| US20230332218A1 (en) | Casy programmable nucleases and rna component systems | |
| WO2022065689A1 (ko) | 편집 효율이 향상된 프라임 편집 기반 유전자 교정용 조성물 및 이의 용도 | |
| US20230295666A1 (en) | Super-enchancers for recombinant gene expression in cho cells | |
| Zheng et al. | Sequence Context‐Agnostic TadA‐Derived Cytosine Base Editors for Genome‐Wide Editing in Zebrafish | |
| KR102679001B1 (ko) | 신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도 | |
| JP7769691B2 (ja) | 新規の改良された塩基編集または編集用融合タンパク質およびその用途 | |
| US20240110163A1 (en) | Crispr-associated based-editing of the complementary strand | |
| JP7109009B2 (ja) | 遺伝子ノックアウト方法 | |
| CN115896149A (zh) | 运动发酵单胞菌基因编辑质粒、试剂盒、方法及应用 |